Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.20 by 31.98 percent. This is a 13.33 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $1.241 billion which beat the analyst consensus estimate of $1.186 billion by 4.67 percent. This is a 21.67 percent increase over sales of $1.020 billion the same period last year.